FilingPulse

KLRS insider transaction filings

Kalaris Therapeutics, Inc. — 35 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-03. Screen KLRS transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-034KEATING LAURIE — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2026-07-204Bayko Liisa Ann — Chief Financial OfficerGrant/award (A): 220,000 (derivative) @ $0EDGAR
2026-06-044Ferrara Napoleone — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-06-044Dybbs Michael — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-06-044Jovan-Embiricos Morana — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-06-044Hallal David — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-06-044ADAMIS ANTHONY P — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-06-044AKKARAJU SRINIVAS — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-06-044PATTERSON LEONE D — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2026-05-224AKKARAJU SRINIVAS — Director, 10% owner
Samsara BioCapital, L.P. — 10% owner
Samsara BioCapital GP, LLC — 10% owner
Samsara Opportunity Fund, L.P. — 10% owner
Samsara Opportunity Fund GP, LLC — 10% owner		Purchase (P): 244,300 @ $4.83 · Other (J): 66,906 @ $0 · Other (J): 14,937 @ $0 · Other (J): 4,471 @ $0EDGAR
2026-03-234Hagen Brett R — Chief Accounting OfficerSale (S): 1,915 @ $6.72 · Grant/award (A): 60,800 (derivative) @ $0EDGAR
2026-03-204Oxtoby Andrew — See Remarks, DirectorGrant/award (A): 222,000 (derivative) @ $0EDGAR
2026-03-204Gall Matthew — Chief Financial OfficerGrant/award (A): 95,000 (derivative) @ $0EDGAR
2026-03-204Feinsod Matthew — Chief Medical OfficerGrant/award (A): 135,000 (derivative) @ $0EDGAR
2026-02-174AKKARAJU SRINIVAS — Director, 10% owner
Samsara BioCapital, L.P. — 10% owner
Samsara BioCapital GP, LLC — 10% owner
Samsara Opportunity Fund, L.P. — 10% owner
Samsara Opportunity Fund GP, LLC — 10% owner		Purchase (P): 479,847 @ $10.42EDGAR
2025-12-224AKKARAJU SRINIVAS — Director, 10% owner
Samsara Opportunity Fund, L.P. — 10% owner
Samsara Opportunity Fund GP, LLC — 10% owner		Grant/award (A): 1,500,000 @ $10EDGAR
2025-11-034Gall Matthew — Chief Financial OfficerGrant/award (A): 235,000 (derivative) @ $0EDGAR
2025-04-114Oxtoby Andrew — See Remarks, DirectorGrant/award (A): 287,000 (derivative) @ $0EDGAR
2025-04-114Ferrara Napoleone — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114Feinsod Matthew — Chief Medical OfficerGrant/award (A): 70,551 (derivative) @ $0 · Grant/award (A): 101,000 (derivative) @ $0EDGAR
2025-04-114Hagen Brett R — Chief Accounting OfficerGrant/award (A): 50,262 (derivative) @ $0EDGAR
2025-04-114Dybbs Michael — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114Jovan-Embiricos Morana — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114Hallal David — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114PATEL SAMIR CHANDRAKANT — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114ADAMIS ANTHONY P — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114AKKARAJU SRINIVAS — Director, 10% ownerGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-04-114PATTERSON LEONE D — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2025-03-274Hagen Brett R — Chief Accounting OfficerSale (S): 907 @ $8.97EDGAR
2025-03-184Oxtoby Andrew — See Remarks, DirectorGrant/award (A): 476,611 (derivative)EDGAR
2025-03-184Ferrara Napoleone — DirectorGrant/award (A): 504,000EDGAR
2025-03-184Feinsod Matthew — Chief Medical OfficerGrant/award (A): 4,030 · Grant/award (A): 28,224 (derivative)EDGAR
2025-03-184PATEL SAMIR CHANDRAKANT — DirectorGrant/award (A): 252,000 · Grant/award (A): 100,800 · Grant/award (A): 105,913 (derivative)EDGAR
2025-03-184ADAMIS ANTHONY P — DirectorGrant/award (A): 19,484 (derivative) · Grant/award (A): 12,989 (derivative)EDGAR
2025-03-184AKKARAJU SRINIVAS — Director, 10% ownerGrant/award (A): 11,444,503EDGAR

Recent 8-K events — Kalaris Therapeutics, Inc.

FiledFormItems reportedSource
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-178-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-048-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-178-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-188-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KLRS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →